HIGHLIGHTS
- who: The Tankyrase, Inhibitor OM- and Demonstrates, from the Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway, Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway. , Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. , Department of Transplant Medicine and Institute for Surgical Research, Oslo University Hospital, Rikshospitalet, Oslo, Norway. , Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. , Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland. , Symeres, Nijmegen, the Netherlands. have published the research . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.